FindTrial
Sign In

research on new treatment of superficial lymph node tuberculosis

research on key technology of superficial lymph node tuberculosis diagnosis and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006908
Enrollment
Unknown
Registered
2015-08-09
Start date
2015-08-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial lymph node tuberculosis

Interventions

the treatment group :Ultrasonic drug import therapy
the control group :No

Sponsors

Beijing Chest Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years, and gender not limited; 2. Accord with "TB diagnosis and treatment guidelines" (formulate by The Chinese medical association of tuberculosis) in the regulation of early superficial lymph node tuberculosis diagnostic criteria; 3. Type B ultrasound and CT examination showed enlargement of lymph nodes; 4. No active tuberculosis stove in the lung; 5. No other extrapulmonary tuberculosis kitchen; 6. Pathological examination showed typical tuberculous lymph node change or tuberculous granuloma.

Exclusion criteria

Exclusion criteria: 1. Having allergies with the drug or any of these ingredients used; 2. Serious damage of liver and kidneys, has a history of mental illness, epilepsy; 3. Pregnant or lactating women; 4. Active pulmonary tuberculosis; 5. With other extrapulmonary tuberculosis; 6. Drug-resistant TB.

Design outcomes

Primary

MeasureTime frame
Lymph node size;The change of abscess and fistula;Local skin irritation, secretion change;Local new lesions;—

Countries

China

Contacts

Public ContactLiu Zhidong
lzdzrd@sina.com+86 13601338599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026